AzTrials
AzTrials

Cerebellar DisordersVITALNCT07621978

Variable Intense Training for Ataxia and Locomotion

A study testing High-intensity training in variable contexts and Conventional balance training in people with Cerebellar Disorders and Cerebellar Degeneration, run by Indiana University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to evaluate the feasibility and potential preliminary efficiency of high-intensity training focused on stepping in variable contexts as compared to conventional training in individuals with cerebellar disease Read more about this study

Who is it for?
Ages 18 to 85 years
What is being tested?
High-intensity training in variable contexts and Conventional balance training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
15 Jun 2026to 15 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ages 18-85
  • >6 months following brain injury or diagnosis of cerebellar dysfunction
  • A total score of > 4 on items 5-8 on the SARA for the ipsilateral limb
  • Ability to ambulate 10 m at self-selected gait speeds (SSV) <1.2 m/s with no greater than minimal physical assistance permitted for postural stability only, but with below knee bracing and/or assistive device as needed
  • Weight < 350 pounds
  • Able to follow 1-step command
  • Medical clearance to participate

Who cannot join

  • Uncontrolled cardiopulmonary or metabolic disease that limits exercise participation, active heterotopic ossification, recurrent history of lower extremity fractures, previous orthopedic or other peripheral or central neurologic injury that may impair locomotor activities
  • Currently participating in other physical therapy
  • >50 units of Botox within the past three months in the lower extremity OR in the lower extremity, but above the knee if the participant wears an ankle-foot-orthosis
  • Individuals deemed not stable between Pre-Baseline Testing and Baseline Testing

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Thomas G Hornby contact

3123508291

tghornby@iu.edu

Christopher Henderson contact

3173292353

henderce@iu.edu

About this study

Official title: Feasibility and Potential Efficacy of High-intensity Gait Training in Individuals With Cerebellar Damage

The goal of this study is to evaluate the feasibility and potential preliminary efficiency of high-intensity training focused on stepping in variable contexts as compared to conventional training in individuals with cerebellar disease

Read the detailed description

The goal of this study is to evaluate the feasibility and potential preliminary efficiency of high-intensity training focused on stepping in variable contexts as compared to conventional training in individuals with cerebellar disease

Being tested
High-intensity training in variable contexts, Conventional balance training
Keywords
Cerebellar diseases, high-intensity training
Medical subject headings
Cerebellar Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-intensity training in variable contextsOther

    Also called Locomotor training at higher intensities

    High intensity stepping training: Training sessions will focus on maximizing stepping activities in variable contexts while targeting ≥70% HR reserve (or approximately 80% age-predicted maximum HR) calculated using the Karvonen formula. Target HR will be decreased by 10 beats if the individual is on beta-blockers. Intensity will also be monitored using the Borg RPE scale every 3-5 minutes with goals of ≥15 on a 6-20 scale. The intensity of the walking training will be primarily modulated through the treadmill speed and incline as well as addition of weights to the torso or limbs for the purpose of error augmentation and not to dampen ataxia. Sessions will focus on achieving up to 40 minutes of stepping training within each 60-minute session. Potential tasks include walking in multiple directions, over inclines and obstacles, and/or with weighted vests and leg weights with limited handrail use as tolerated and decided by the therapist and participant.

  • Conventional balance trainingOther

    Also called Static and dynamic stability training

    Conventional training: Training sessions will focus on improving static and dynamic balance, while calculated using the Karvonen formula. Target HR ranges will be decreased by 10 beats if the individual is on beta-blockers. Intensity will also be monitored using heart rates and RPE every 3-5 minutes with goals of <14 on a 6-20 scale. Sessions will focus on balance training for up to 40 minutes within a 60-minute session. Individuals will perform ~10 minutes (~25% of sessions) on balance activities in the sitting position, ~20 minutes (50% of sessions) of standing positions and ~10 minutes (25% of sessions) of walking training.

Study groups in NCT07621978
Study groupRoleWhat they receive
High-intensity training in variable contextsExperimentalHigh-intensity training focused on stepping tasks in variable contexts (tasks and environments) while targeting higher cardiovascular intensity (>75% maximum predicted heart rates) during up to 40 mins of 1-hr sessions. A total of 20 sessions will be targeted.
Receives: Other: High-intensity training in variable contexts
Conventional balance trainingActive comparatorConventional balance activities will consist of sitting and standing balance exercises, with selected dynamic stability exercises performed during walking tasks. Heart rates will be monitored with no targeted range. All sessions will be 1-hr long with balance activities for up to 40 minutes per session. A total of 20 sessions will be targeted.
Receives: Other: Conventional balance training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 6-min walk test

    Participants will walk for 6 minutes with instructions to "cover as much ground as they can".

    Measured: Changes from baseline to post-training following up to 20 sessions over approximately 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2026
  2. Study start15 Jun 2026 (estimated)
  3. Primary completion15 Jun 2028 (estimated)
  4. Study completion15 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Randomized, controlled cross-over trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07621978
Sponsor's protocol ID
IU31611
Acronym
VITAL
Status last verified
May 2026
First submitted
27 May 2026
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Keller JL, Bastian AJ. A home balance exercise program improves walking in people with cerebellar ataxia. Neurorehabil Neural Repair. 2014 Oct;28(8):770-8. doi: 10.1177/1545968314522350. Epub 2014 Feb 13.

    PubMed 24526707
  • Hornby TG, Henderson CE, Plawecki A, Lucas E, Lotter J, Holthus M, Brazg G, Fahey M, Woodward J, Ardestani M, Roth EJ. Contributions of Stepping Intensity and Variability to Mobility in Individuals Poststroke. Stroke. 2019 Sep;50(9):2492-2499. doi: 10.1161/STROKEAHA.119.026254. Epub 2019 Aug 22.

    PubMed 31434543

Questions about this trial

What is this clinical trial studying?

A study testing High-intensity training in variable contexts and Conventional balance training in people with Cerebellar Disorders and Cerebellar Degeneration, run by Indiana University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Thomas G Hornby (3123508291, tghornby@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

6-min walk test (time frame: Changes from baseline to post-training following up to 20 sessions over approximately 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07621978, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in